Neuroleptic Malignant Syndrome: A Primary Care Perspective

AUTOR(ES)

Gupta, Sanjay

FONTE

Physicians Postgraduate Press

RESUMO

In recent years, there has been an increased use of neuroleptic agents in the primary care setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy that can be missed if not suspected. This manuscript reviews the diagnosis and management of NMS in the primary care setting. There is a lack of prospective data, and most of the information is obtained from case series. Physicians need to have a high index of suspicion with regard to excluding NMS in patients taking neuroleptics and presenting with hyperthermia.

Documentos Relacionados

• Neuroleptic malignant syndrome: case report and discussion
• Clomipramine and neuroleptic malignant syndrome: Authors' reply
• BOOK REVIEWS: Neuroleptic Malignant Syndrome: A Clinical Approach. A Mosby Year Book.
• Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?
• Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology.